Association between proton pump inhibitors after percutaneous coronary intervention and risk of gastric cancer
Background Previous studies showing an association between chronic use of proton pump inhibitor (PPI) and gastric cancer are limited by confounding by indication. This relationship has not been studied in patients receiving PPI for prophylaxis, such as those undergoing percutaneous coronary interven...
Saved in:
| Main Authors: | Ka-Shing Cheung, Chung-Wah Siu, Andrew Kei-Yan Ng, Pauline Yeung Ng, April Ip |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-10-01
|
| Series: | BMJ Open Gastroenterology |
| Online Access: | https://bmjopengastro.bmj.com/content/8/1/e000719.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Proton Pump Inhibitors and Gastric Cancer
by: Seungkyung Kang, et al.
Published: (2021-09-01) -
Atherothrombotic Outcomes After Sodium‐Glucose Cotransporter 2 Inhibitors Versus Dipeptidyl Peptidase‐4 Inhibitors in Patients With Type 2 Diabetes: A Territory‐Wide Retrospective Cohort Study
by: Pauline Yeung Ng, et al.
Published: (2025-01-01) -
Proton-pump inhibitors
by: Vasudevan G. Naidoo
Published: (2015-05-01) -
Safety of proton pump inhibitors
by: Ye. A. Losik
Published: (2016-08-01) -
Deprescribing proton pump inhibitors
by: Kim Jun Kevin Teh, et al.
Published: (2023-08-01)